Legartov xe1 S, Fagherazzi P, Goswami P, Brazda V, Lochmanov xe1 G, Koutn xe1 I, et al. Irradiation potentiates p53 phosphorylation and p53 binding to the promoter and coding region of the TP53 gene. Biochimie. 2022;: pubmed publisher

Liu Y, Wang X, Zhu W, Sui Z, Wei X, Zhang Y, et al. TRPML1-induced autophagy inhibition triggers mitochondrial mediated apoptosis. Cancer Lett. 2022;541:215752 pubmed publisher

Galhuber M, Michenthaler H, Heininger C, Reinisch I, Nössing C, Krstić J, et al. Complementary omics strategies to dissect p53 signaling networks under nutrient stress. Cell Mol Life Sci. 2022;79:326 pubmed publisher

Wang Y, Ho T, Hariharan A, Goh H, Wong Y, Verkaik N, et al. Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity. Proc Natl Acad Sci U S A. 2022;119:e2113233119 pubmed publisher

Xing Y, Wei X, Liu Y, Wang M, Sui Z, Wang X, et al. Autophagy inhibition mediated by MCOLN1/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53/p53 pathway. Autophagy. 2021;:1-23 pubmed publisher

He H, Lin X, Wu D, Wang J, Guo J, Green D, et al. Enzymatic Noncovalent Synthesis for Mitochondrial Genetic Engineering of Cancer Cells. Cell Rep Phys Sci. 2020;1: pubmed publisher

Mitra S, Veppil Muralidharan S, Di Marco M, Juvvuna P, Thankaswamy Kosalai S, Reischl S, et al. Subcellular distribution of p53 by the p53-responsive lncRNA NBAT1 determines chemotherapeutic response in neuroblastoma. Cancer Res. 2020;: pubmed publisher

Anderson C, Routes T, Eckhardt L, Delisle B, January C, Kamp T. A rapid solubility assay of protein domain misfolding for pathogenicity assessment of rare DNA sequence variants. Genet Med. 2020;: pubmed publisher

Huber S, Bär A, Epp S, Schmuckli Maurer J, Eberhard N, Humbel B, et al. Recruitment of Host Nuclear Pore Components to the Vicinity of Theileria Schizonts. mSphere. 2020;5: pubmed publisher

Tyagi M, Bauri A, Chattopadhyay S, Patro B. Thiol antioxidants sensitize malabaricone C induced cancer cell death via reprogramming redox sensitive p53 and NF-κB proteins in vitro and in vivo. Free Radic Biol Med. 2020;148:182-199 pubmed publisher

Fifield B, Qemo I, Kirou E, Cardiff R, Porter L. The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis. Breast Cancer Res. 2019;21:140 pubmed publisher

Dabiri Y, Abu El Maaty M, Chan H, Wölker J, Ott I, Wolfl S, et al. p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells. Front Oncol. 2019;9:438 pubmed publisher

Rinaldi L, Folliero V, Palomba L, Zannella C, Isticato R, Di Francia R, et al. Sonoporation by microbubbles as gene therapy approach against liver cancer. Oncotarget. 2018;9:32182-32190 pubmed publisher

Chen B, Wang J, Wang J, Wang H, Gu X, Tang L, et al. A regulatory circuitry comprising TP53, miR-29 family, and SETDB1 in non-small cell lung cancer. Biosci Rep. 2018;38: pubmed publisher

Agarwal S, Milazzo G, Rajapakshe K, Bernardi R, Chen Z, Barberi E, et al. MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma. Oncotarget. 2018;9:20323-20338 pubmed publisher

Goiran T, Duplan E, Rouland L, El Manaa W, Lauritzen I, Dunys J, et al. Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation. Cell Death Differ. 2018;25:873-884 pubmed publisher

Weecharangsan W, Opanasopit P, Niyomtham N, Yingyongnarongkul B, Kewsuwan P, Lee R. Synergistic Inhibition of Human Carcinoma Cell Growth via Co-Delivery of p53 Plasmid DNA and bcl-2 Antisense Oligodeoxyribonucleotide by Cholic Acid-modified Polyethylenimine. Anticancer Res. 2017;37:6335-6340 pubmed

Gabrielsen M, Buetow L, Nakasone M, Ahmed S, Sibbet G, Smith B, et al. A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants. Mol Cell. 2017;68:456-470.e10 pubmed publisher

Tran L, Kichenadasse G, Butler L, Centenera M, Morel K, Ormsby R, et al. The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer. Mol Cancer Ther. 2017;16:2689-2700 pubmed publisher

Ghosh S, Salot S, Sengupta S, Navalkar A, Ghosh D, Jacob R, et al. p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis. Cell Death Differ. 2017;24:1784-1798 pubmed publisher

Nguyen D, Richter D, Michel G, Mitschka S, Kolanus W, Cuevas E, et al. The ubiquitin ligase LIN41/TRIM71 targets p53 to antagonize cell death and differentiation pathways during stem cell differentiation. Cell Death Differ. 2017;24:1063-1078 pubmed publisher

Omar H, Tolba M, Hung J, Al Tel T. OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKC?/p53. Front Pharmacol. 2016;7:463 pubmed

Ni T, Li X, Lu N, An T, Liu Z, Fu R, et al. Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer. Nat Cell Biol. 2016;18:1221-1232 pubmed publisher

Hussain T, Schneider M, Summer B, Strieth S. Pre-operative in vitro fibroblast coating of porous polyethylene compound grafts - Cell survival in vivo and effects on biocompatibility. Biomed Mater Eng. 2016;27:237-49 pubmed publisher

Fern ndez Majada V, Welz P, Ermolaeva M, Schell M, Adam A, Dietlein F, et al. The tumour suppressor CYLD regulates the p53 DNA damage response. Nat Commun. 2016;7:12508 pubmed publisher

Bechill J, Zhong R, Zhang C, Solomaha E, Spiotto M. A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53. PLoS ONE. 2016;11:e0154125 pubmed publisher

Stixová L, Sehnalová P, Legartová S, Suchánková J, Hrušková T, Kozubek S, et al. HP1β-dependent recruitment of UBF1 to irradiated chromatin occurs simultaneously with CPDs. Epigenetics Chromatin. 2014;7:39 pubmed publisher

Martino Echarri E, Henderson B, Brocardo M. Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy. Oncotarget. 2014;5:9889-900 pubmed

Chen B, Suen Y, Gu S, Li L, Chan W. A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor. Sci Rep. 2014;4:6413 pubmed publisher

Herce H, Deng W, Helma J, Leonhardt H, Cardoso M. Visualization and targeted disruption of protein interactions in living cells. Nat Commun. 2013;4:2660 pubmed publisher

Liao W, Liaw C, Huang Y, Han H, Hsu H, Hwang S, et al. Cyclohexylmethyl Flavonoids Suppress Propagation of Breast Cancer Stem Cells via Downregulation of NANOG. Evid Based Complement Alternat Med. 2013;2013:170261 pubmed publisher

Stixova L, Bartova E, Matula P, Danek O, Legartova S, Kozubek S. Heterogeneity in the kinetics of nuclear proteins and trajectories of substructures associated with heterochromatin. Epigenetics Chromatin. 2011;4:5 pubmed publisher

Boyd S, Tsai K, Jacks T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol. 2000;2:563-8 pubmed